Other

Aventis Pharma S.a.

Centre National De La Recherche Scientifique

Assistance Publique-Hopitaux De Paris

Université Paris Descartes

Godtech

Marc Abitbol

Carine Bossard

Yves Uteza

Martin Neuner-Jehle

Jiri Honiger

Maurice Menasche

Herv&eacute; Prats

Lo&iuml;c Van Den Berghe

Michel Perricaudet

Jacques Mallet

Emmanuelle Vigne

Fr&eacute;d&eacute;ric Revah

S&eacute;bastien Bonnel

Loic Van Den Berghe

Paul Roustan

Sebastian Bonnel

S&eacute;bastian Bonnel

Armelle Rametti-Lacroux

Aurore Burgain-Chain

Véronique Vieira

Recombinant adenoviruses comprising a heterologous DNA sequence coding for basic blast growth factors (bFGF), preparation and uses thereof for the treatment and/or prevention of neurodegenerative diseases.

Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)

Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.

Intraocular transplantation of encapsulated cells

Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-anglogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.

Growing community of inventors

Paris, France

Marc Abitbol